Subsequently, several studies have found that the expression level of lncRNA FOXD2-AS1 is upregulated in ovarian, gastric, and bladder cancer and is closely related to the proliferation, migration, invasion, and tumor prognosis of tumor cells, which can be used as a potential target for cancer treatment and prognosis [15–17]. The gene discussed is FOXD2; the disease is urinary bladder cancer.